{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:37:20Z","timestamp":1791920240285,"version":"4.3.4"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Alzheimer's Disease (AD) is a devastating neurological condition characterized by a\nprogressive decline in cognitive function, including memory loss, reasoning difficulties, and\ndisorientation. Its hallmark features include the formation of neurofibrillary tangles and neuritic\nplaques in the brain, disrupting normal neuronal function. Neurofibrillary tangles, composed of\nphosphorylated tau protein and neuritic plaques, containing amyloid-&amp;#946; protein (A&amp;#946;) aggregates,\ncontribute to the degenerative process. The discovery of the beta-site amyloid precursor protein\ncleaving enzyme 1 (BACE1) in 1999 revolutionized our understanding of AD pathogenesis.\nBACE1 plays a crucial role in the production of A&amp;#946;, the toxic protein implicated in AD progression.\nElevated levels of BACE1 have been observed in AD brains and bodily fluids, underscoring\nits significance in disease onset and progression. Despite setbacks in clinical trials of\nBACE1 inhibitors due to efficacy and safety concerns, targeting BACE1 remains a promising\ntherapeutic strategy for early-stage AD. Natural flavonoids have emerged as potential BACE1\ninhibitors, demonstrating the ability to reduce A&amp;#946; production in neuronal cells and inhibit\nBACE1 activity. In our review, we delve into the pathophysiology of AD, highlighting the central\nrole of BACE1 in A&amp;#946; production and disease progression. We explore the therapeutic potential\nof BACE1 inhibitors, including natural flavonoids, in controlling AD symptoms. Additionally,\nwe provide insights into ongoing clinical trials and available patents in this field, shedding\nlight on future directions for AD treatment research.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118715249315049240710063455","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:02:03Z","timestamp":1721030523000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beta-site APP-cleaving Enzyme-1 Inhibitory Role of Natural Flavonoids in the Treatment of Alzheimer's Disease"],"prefix":"10.2174","volume":"25","author":[{"given":"Sandeep","family":"Singh","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P. India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Kushwaha","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P. India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram","family":"Sisodia","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P. India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-6981","authenticated-orcid":true,"given":"Shivendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, U.P. India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kantrol Kumar","family":"Sahu","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, U.P. India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1016\/j.mehy.2020.109839","volume":"143","author":"Chetia P.","year":"2020","unstructured":"Chetia P.; Mazumder M.K.; Mahanta S.; De B.; Dutta Choudhury M.; A novel phytochemical from Dipteris wallichii inhibits human \u03b2-secretase 1: Implications for the treatment of Alzheimer\u2019s disease. Med Hypotheses  2020,143,109839","journal-title":"Med Hypotheses"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"106536","DOI":"10.1016\/j.bpc.2020.106536","volume":"270","author":"Ugbaja S.C.","year":"2021","unstructured":"Ugbaja S.C.; Sanusi Z.K.; Appiah-Kubi P.; Lawal M.M.; Kumalo H.M.; Computational modelling of potent \u03b2-secretase (BACE1) inhibitors towards Alzheimer\u2019s disease treatment. Biophys Chem  2021,270,106536","journal-title":"Biophys Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1039\/C3CS60460H","volume":"43","author":"Ghosh A.K.","year":"2014","unstructured":"Ghosh A.K.; Osswald H.L.; BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer\u2019s disease. Chem Soc Rev  2014,43(19),6765-6813","journal-title":"Chem Soc Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/ph12010041","volume":"12","author":"Maia M.A.","year":"2019","unstructured":"Maia M.A.; Sousa E.; BACE-1 and \u03b3-Secretase as Therapeutic Targets for Alzheimer\u2019s Disease. Pharmaceuticals (Basel)  2019,12(1),41","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.3390\/app13084651","volume":"13","author":"Lima E.","year":"2023","unstructured":"Lima E.; Rauter A.; Medeiros J.; Flavonoids as Promising Multitarget Agents in Alzheimer\u2019s Disease Therapy. Appl Sci (Basel)  2023,13(8),4651","journal-title":"Appl Sci (Basel)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"105486","DOI":"10.1016\/j.neuint.2023.105486","volume":"163","author":"Punmiya A.","year":"2023","unstructured":"Punmiya A.; Prabhu A.; Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer\u2019s disease. Neurochem Int  2023,163,105486","journal-title":"Neurochem Int"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2174\/1389557519666190617150051","volume":"20","author":"Calis Z.","year":"2020","unstructured":"Calis Z.; Mogulkoc R.; Baltaci A.K.; The Roles of Flavonols\/Flavonoids in Neurodegeneration and Neuroinflammation. Mini Rev Med Chem  2020,20(15),1475-1488","journal-title":"Mini Rev Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.3390\/molecules25225243","volume":"25","author":"Ullah A.","year":"2020","unstructured":"Ullah A.; Munir S.; Badshah S.L.; Khan N.; Ghani L.; Poulson B.G.; Emwas A.H.; Jaremko M.; Important Flavonoids and Their Role as a Therapeutic Agent. Molecules  2020,25(22),5243","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.3390\/ijms232314835","volume":"23","author":"Calderaro A.","year":"2022","unstructured":"Calderaro A.; Patan\u00e8 G.T.; Tellone E.; Barreca D.; Ficarra S.; Misiti F.; Lagan\u00e0 G.; The Neuroprotective Potentiality of Flavonoids on Alzheimer\u2019s Disease. Int J Mol Sci  2022,23(23),14835","journal-title":"Int J Mol Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"119164","DOI":"10.1016\/j.bbamcr.2021.119164","volume":"1869","author":"Armbrust F.","year":"2022","unstructured":"Armbrust F.; Bickenbach K.; Marengo L.; Pietrzik C.; Becker-Pauly C.; The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative \u03b2-secretases. Biochim Biophys Acta Mol Cell Res  2022,1869(3),119164","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ajcn\/nqaa079","volume":"112","author":"Shishtar E.","year":"2020","unstructured":"Shishtar E.; Rogers G.T.; Blumberg J.B.; Au R.; Jacques P.F.; Long-term dietary flavonoid intake and risk of Alzheimer disease and related dementias in the Framingham Offspring Cohort. Am J Clin Nutr  2020,112(2),343-353","journal-title":"Am J Clin Nutr"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1038\/s41598-022-07302-4","volume":"12","author":"Bonyadi N.","year":"2022","unstructured":"Bonyadi N.; Dolatkhah N.; Salekzamani Y.; Hashemian M.; Effect of berry-based supplements and foods on cognitive function: a systematic review. Sci Rep  2022,12(1),3239","journal-title":"Sci Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.36349\/easjpp.2022.v04i02.003","volume":"4","author":"Abushwereb H.S.","year":"2022","unstructured":"Abushwereb H.S.; Does food have anything to do with Memory and Intelligence? A Review on Alzheimer\u2019s disease Fighting. EAS Journal of Pharmacy and Pharmacology  2022,4(2),35-42","journal-title":"EAS Journal of Pharmacy and Pharmacology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.trci.2018.09.002","volume":"5","author":"Colizzi C.","year":"2019","unstructured":"Colizzi C.; The protective effects of polyphenols on Alzheimer\u2019s disease: A systematic review. Alzheimers Dement (N Y)  2019,5(1),184-196","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1023\/A:1007614613771","volume":"16","author":"Commenges D.","year":"2000","unstructured":"Commenges D.; Scotet V.; Renaud S.; Jacqmin-Gadda H.; Barberger-Gateau P.; Dartigues J.F.; Intake of flavonoids and risk of dementia. Eur J Epidemiol  2000,16(4),357-363","journal-title":"Eur J Epidemiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines9020099","volume":"9","author":"Devi S.","year":"2021","unstructured":"Devi S.; Kumar V.; Singh S.K.; Dubey A.K.; Kim J.J.; Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders. Biomedicines  2021,9(2),99","journal-title":"Biomedicines"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","volume":"29","author":"Vassar R.","year":"2009","unstructured":"Vassar R.; Kovacs D.M.; Yan R.; Wong P.C.; The beta-secretase enzyme BACE in health and Alzheimer\u2019s disease: regulation, cell biology, function, and therapeutic potential. J Neurosci  2009,29(41),12787-12794","journal-title":"J Neurosci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"Hampel H.","year":"2021","unstructured":"Hampel H.; Vassar R.; De Strooper B.; Hardy J.; Willem M.; Singh N.; Zhou J.; Yan R.; Vanmechelen E.; De Vos A.; Nistic\u00f2 R.; Corbo M.; Imbimbo B.P.; Streffer J.; Voytyuk I.; Timmers M.; Tahami Monfared A.A.; Irizarry M.; Albala B.; Koyama A.; Watanabe N.; Kimura T.; Yarenis L.; Lista S.; Kramer L.; Vergallo A.; The \u03b2-Secretase BACE1 in Alzheimer\u2019s Disease. Biol Psychiatry  2021,89(8),745-756","journal-title":"Biol Psychiatry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"8631","DOI":"10.1073\/pnas.1708106114","volume":"114","author":"Keskin A.D.","year":"2017","unstructured":"Keskin A.D.; Keku\u0161 M.; Adelsberger H.; Neumann U.; Shimshek D.R.; Song B.; Zott B.; Peng T.; F\u00f6rstl H.; Staufenbiel M.; Nelken I.; Sakmann B.; Konnerth A.; Busche M.A.; BACE inhibition-dependent repair of Alzheimer\u2019s pathophysiology. Proc Natl Acad Sci USA  2017,114(32),8631-8636","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","volume":"378","author":"Egan M.F.","year":"2018","unstructured":"Egan M.F.; Kost J.; Tariot P.N.; Aisen P.S.; Cummings J.L.; Vellas B.; Sur C.; Mukai Y.; Voss T.; Furtek C.; Mahoney E.; Harper Mozley L.; Vandenberghe R.; Mo Y.; Michelson D.; Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer\u2019s Disease. N Engl J Med  2018,378(18),1691-1703","journal-title":"N Engl J Med"},{"key":"ref=21","first-page":"1483","volume":"380","author":"Henley D.","year":"2019","unstructured":"Henley D.; Raghavan N.; Sperling R.; Aisen P.; Raman R.; Romano G.;  Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer\u2019s Disease  2019,380,1483-1485","journal-title":"Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer\u2019s Disease"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/jmf.2014.3150","volume":"18","author":"Ma W.","year":"2015","unstructured":"Ma W.; Ding B.; Yu H.; Yuan L.; Xi Y.; Xiao R.; Genistein alleviates \u03b2-amyloid-induced inflammatory damage through regulating Toll-like receptor 4\/nuclear factor \u03baB. J Med Food  2015,18(3),273-279","journal-title":"J Med Food"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1055\/a-1019-9819","volume":"85","author":"Naushad M.","year":"2019","unstructured":"Naushad M.; Durairajan S.S.K.; Bera A.K.; Senapati S.; Li M.; Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer\u02bcs Disease. Planta Med  2019,85(17),1316-1325","journal-title":"Planta Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/antiox12020280","volume":"12","author":"Bellavite P.","year":"2023","unstructured":"Bellavite P.; Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action. Antioxidants  2023,12(2),280","journal-title":"Antioxidants"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"16127","DOI":"10.1038\/srep16127","volume":"5","author":"Wang X.","year":"2015","unstructured":"Wang X.; Perumalsamy H.; Kwon H.W.; Na Y.E.; Ahn Y.J.; Effects and possible mechanisms of action of acacetin on the behavior and eye morphology of Drosophila models of Alzheimer\u2019s disease. Sci Rep  2015,5(1),16127","journal-title":"Sci Rep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.3390\/molecules25184064","volume":"25","author":"Tran T.S.","year":"2020","unstructured":"Tran T.S.; Tran T.D.; Tran T.H.; Mai T.T.; Nguyen N.L.; Thai K.M.; Le M.T.; Synthesis, In Silico and In Vitro Evaluation of Some Flavone Derivatives for Acetylcholinesterase and BACE-1 Inhibitory Activity. Molecules  2020,25(18),4064","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"Panche A.N.","year":"2016","unstructured":"Panche A.N.; Diwan A.D.; Chandra S.R.; Flavonoids: an overview. J Nutr Sci  2016,5,e47","journal-title":"J Nutr Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1248\/cpb.c15-00504","volume":"63","author":"Jung H.J.","year":"2015","unstructured":"Jung H.J.; Jung H.A.; Min B.S.; Choi J.S.; Anticholinesterase and \u03b2-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitory Compounds from the Heartwood of <i>Juniperus chinensis<\/i>. Chem Pharm Bull (Tokyo)  2015,63(11),955-960","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06751.x","volume":"114","author":"Zhu Z.","year":"2010","unstructured":"Zhu Z.; Li C.; Wang X.; Yang Z.; Chen J.; Hu L.; Jiang H.; Shen X.; 2,2\u2032,4\u2032\u2010Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. J Neurochem  2010,114(2),374-385","journal-title":"J Neurochem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1016\/j.bmc.2008.05.080","volume":"16","author":"Hwang E.M.","year":"2008","unstructured":"Hwang E.M.; Ryu Y.B.; Kim H.Y.; Kim D.G.; Hong S.G.; Lee J.H.; Curtis-Long M.J.; Jeong S.H.; Park J.Y.; Park K.H.; BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens. Bioorg Med Chem  2008,16(14),6669-6674","journal-title":"Bioorg Med Chem"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2174\/156802609789941942","volume":"9","author":"Fang W.S.","year":"2009","unstructured":"Fang W.S.; Zhang J.; Natural products. Curr Top Med Chem  2009,9,1597","journal-title":"Curr Top Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1142\/S0192415X10007944","volume":"38","author":"Jung H.A.","year":"2010","unstructured":"Jung H.A.; Yokozawa T.; Kim B.W.; Jung J.H.; Choi J.S.; Selective inhibition of prenylated flavonoids from Sophora flavescens against BACE1 and cholinesterases. Am J Chin Med  2010,38(2),415-429","journal-title":"Am J Chin Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1016\/j.bmcl.2010.06.021","volume":"20","author":"Sasaki H.","year":"2010","unstructured":"Sasaki H.; Miki K.; Kinoshita K.; Koyama K.; Juliawaty L.D.; Achmad S.A.; Hakim E.H.; Kaneda M.; Takahashi K.; \u03b2-Secretase (BACE-1) inhibitory effect of biflavonoids. Bioorg Med Chem Lett  2010,20(15),4558-4560","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fnagi.2013.00098","volume":"5","author":"Grimm M.O.W.","year":"2013","unstructured":"Grimm M.O.W.; Mett J.; Stahlmann C.P.; Haupenthal V.J.; Zimmer V.C.; Hartmann T.; Neprilysin and A\u03b2 clearance: Impact of the APP intracellular domain in NEP regulation and implications in Alzheimer\u2019s Disease. Front Aging Neurosci  2013,5,98","journal-title":"Front Aging Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.08.030","volume":"362","author":"Yamamoto N.","year":"2017","unstructured":"Yamamoto N.; Shibata M.; Ishikuro R.; Tanida M.; Taniguchi Y.; Ikeda-Matsuo Y.; Sobue K.; Epigallocatechin gallate induces extracellular degradation of amyloid \u03b2-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. Neuroscience  2017,362,70-78","journal-title":"Neuroscience"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yexcr.2015.04.004","volume":"334","author":"Chang X.","year":"2015","unstructured":"Chang X.; Rong C.; Chen Y.; Yang C.; Hu Q.; Mo Y.; Zhang C.; Gu X.; Zhang L.; He W.; Cheng S.; Hou X.; Su R.; Liu S.; Dun W.; Wang Q.; Fang S.; (\u2212)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer\u05f3s disease model mice by upregulating neprilysin expression. Exp Cell Res  2015,334(1),136-145","journal-title":"Exp Cell Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jnutbio.2012.10.005","volume":"24","author":"Lim H.J.","year":"2013","unstructured":"Lim H.J.; Shim S.B.; Jee S.W.; Lee S.H.; Lim C.J.; Hong J.T.; Sheen Y.Y.; Hwang D.Y.; Green tea catechin leads to global improvement among Alzheimer\u2019s disease-related phenotypes in NSE\/hAPP-C105 Tg mice. J Nutr Biochem  2013,24(7),1302-1313","journal-title":"J Nutr Biochem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/nu8020090","volume":"8","author":"Semwal D.","year":"2016","unstructured":"Semwal D.; Semwal R.; Combrinck S.; Viljoen A.; Myricetin: A dietary molecule with diverse biological activities. Nutrients  2016,8(2),90","journal-title":"Nutrients"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bmc.2015.12.021","volume":"24","author":"Hanaki M.","year":"2016","unstructured":"Hanaki M.; Murakami K.; Akagi K.; Irie K.; Structural insights into mechanisms for inhibiting amyloid \u03b242 aggregation by non catechol-type flavonoids. Bioorg Med Chem  2016,24(2),304-313","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/BPL-200098","volume":"6","author":"Hole K.L.","year":"2021","unstructured":"Hole K.L.; Williams R.J.; Flavonoids as an intervention for Alzheimer\u2019s Disease: Progress and hurdles towards defining a mechanism of action1. Brain Plast  2021,6(2),167-192","journal-title":"Brain Plast"},{"key":"ref=41","author":"Bredesen V.J.E.","unstructured":"Bredesen V.J.E.; App specific bace inhibitors (asbis) and uses thereof."},{"key":"ref=42","author":"Jensen K.J.M.T.","unstructured":"Jensen K.J.M.T.; 2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer\u2019s disease"},{"key":"ref=43","author":"Hilpert","unstructured":"Hilpert ; Hanshum ; Roland M.; Torsten S.; Christian V.; Rogel W. T.; BACE1 inhibitor [Internet].  Available from:  https:\/\/patents.google.com\/patent\/JP6574756B2\/ja?oq=JP6574756B2"},{"key":"ref=44","author":"Woltering T.","unstructured":"Woltering T.; Halogen-alkyl-1,3 oxazines as BACE1 and\/or BACE2 inhibitors."}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249315049240710063455","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231922\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249315049240710063455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:12:40Z","timestamp":1733728360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231922\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715249315049240710063455","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}